Use of Antimicrobial Peptides Against Microbial Biofilms: Advantages and Limits
Keywords: Actinobacillus; Antimicrobial peptides; Candida albicans; Histatin 5; Lactoferrin; Microbial Biofilms; Omiganan; Phyllomedusa; Piperacillin-tazobactam; Quorum sensing; Stenotrophomonas malthophilia; acyl ho-moserine lactone (AHLs); agglomerates; albumin; amphotericin B; antibiotic resistance; antibiotics; antimicrobial activity; arginine; benzalkonium; biofilm; cathelicidin; cecropins; central venous catheters; chronic prostatitis; cystic fibrosis; defensin-3; dental acrylic; exopolysaccharides; glucuronoxylomannan; glycosaminoglycans; haematogeneous osteomyelitis; kappacin; linezolid; lipopolysaccharide; magainins; medical device; membranolytic activity; meta-phenylene ethynylene; methicillin-resistant; methicillin-susceptible; octadecapeptide; otitis media; peptidomimetics; periodontitis; piperacillin-tazobactam; poly-glutammic acid; quorum-sensing; rifampicin; tachiplesin III; tryptophan; urinary catheters; vancomycin; vancomycin-resistant
Document Type: Research Article
Publication date: 01 January 2011
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content